The investment was led by Verdane to support the company as it grows its commercial solar footprint across Europe.
"Securing this €26 million funding from Verdane marks a pivotal moment for UrbanVolt as we set our sights on an ambitious European expansion. We are thrilled to have the support of Verdane, a renowned specialist growth investor and fellow certified B Corp company, who share our vision for a sustainable future."
The financing round was co-led by World Fund and CPT Capital to help scale sustainable protein production in Europe.
"Our strides in launching the new factory in the Netherlands and expanding collaborations across the UK and Europe have been significant. This fresh funding will drive accelerated growth."
Golden Record Ventures led the £5m growth round to help Orbital expand its licensing and product offerings.
"We believe all modern, global companies will require access to both blockchain and fiat payment rails, from one single platform, to effectively manage their business in the future. Orbital has been built by veterans who deeply understand the needs of large enterprises, which until now have been massively underserved. Our combined expertise in both traditional finance and crypto means that we are uniquely positioned to serve their demands. Bootstrapped and profitable since 2017, we’ve both grown rapidly and raised financing in a very difficult crypto bear market. Now we’re ready to scale even further and push our platform towards the bleeding edge of fintech."
— Luke Wingfield-Digby, Co-founder and Head of Corporate Development
Finch Capital led the funding round, which will support international expansion and product development.
"Finch proved to be the most adaptable and thorough in its evaluation of eflow’s business and future plans, added to which it has relevant contacts in this market sector of tier two financial institutions, where eflow is focused."
The Oxford-based medical technology company secured backing from Lauxera Capital Partners to expand its US footprint and advance research pipelines.
"Lauxera is proud and honoured to back the OrganOx team and its global commercial scale-up. This is the ninth investment made by Lauxera Growth I, a growth buy-out fund dedicated to investing in commercial-stage European and North American HealthTech businesses."